Literature DB >> 9204959

Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients.

V De Laurenzi1, G R Rogers, E Tarcsa, G Carney, L Marekov, S J Bale, J G Compton, N Markova, P M Steinert, W B Rizzo.   

Abstract

Sjögren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by congenital ichthyosis, mental retardation, and spastic diplegia or tetraplegia. Patients with SLS have deficient activity of fatty aldehyde dehydrogenase (FALDH), an enzyme involved in long-chain fatty alcohol oxidation. The cDNA encoding FALDH has recently been cloned and several different mutations have been found in SLS patients. We have now identified a point mutation (C943 --> T) in 7 of 19 kindreds of European descent, accounting for 24% of the SLS alleles. The C943T mutation was only found in patients of northern European ancestry from Sweden, the Netherlands, Germany, and Belgium. Haplotype analysis suggested that the patients carrying the C943T allele were distantly related. All four Swedish patients were homozygous for C943T, indicating that this mutation is probably the major cause of SLS in the inbred Swedish families. The mutation leads to the substitution of serine for the highly conserved proline 315 in the FALDH protein, and expression studies confirm that it destroys enzymatic activity. The mutation was readily detected with an MnlI restriction enzyme digestion test. The finding that C943T is a common SLS mutation in northern European and Swedish patients affords a rapid simple method for diagnosing SLS by screening patients for this mutation with DNA-based methods.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204959     DOI: 10.1111/1523-1747.ep12276622

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Molecular basis of Sjögren-Larsson syndrome: frequency of the 1297-1298 del GA and 943C-->T mutation in 29 patients.

Authors:  L Ijlst; W Oostheim; M van Werkhoven; M A Willemsen; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Sjögren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene.

Authors:  M P Auada; M B Puzzi; M L Cintra; C E Steiner; F Alexandrino; E L Sartorato; T S Aguiar; R D Azulay; G Carney; W B Rizzo
Journal:  Br J Dermatol       Date:  2006-04       Impact factor: 9.302

3.  The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.

Authors:  W B Rizzo; G Carney; Z Lin
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 4.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

5.  Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.

Authors:  Mohamed S Abdel-Hamid; Mahmoud Y Issa; Hasnaa M Elbendary; Sherif F Abdel-Ghafar; Karima Rafaat; Heba Hosny; Marian Girgis; Ghada M H Abdel-Salam; Maha S Zaki
Journal:  J Hum Genet       Date:  2019-07-05       Impact factor: 3.172

6.  Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.

Authors:  Kathleen Davis; Kenton R Holden; Dana S'Aulis; Claudia Amador; M Gisele Matheus; William B Rizzo
Journal:  J Child Neurol       Date:  2012-10-03       Impact factor: 1.987

Review 7.  Sjogren-Larsson Syndrome: Mechanisms and Management.

Authors:  Parayil Sankaran Bindu
Journal:  Appl Clin Genet       Date:  2020-01-07

8.  A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

Authors:  Simone Warrack; Terri Love; William B Rizzo
Journal:  J Child Neurol       Date:  2021-07-28       Impact factor: 1.987

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.